Pioneering public forum on Alzheimer's disease at UWE Bristol chaired by Jonathan Dimbleby

Issue date: 25 September 2013


BRACE Logo

BRACE Dementia debate UWE Bristol Exhibition and Conference Centre 3 October 2013 at 19:00

Local Alzheimer's disease charity BRACE has convened a panel of experts who will lead a discussion about issues relating to Alzheimer's Disease (AD) chaired by Jonathan Dimbleby at the University of the West of England on 3 October 2013.

The event is an excellent opportunity for health practitioners, researchers, patients and carers to find out from leading experts about research developments happening locally and to discuss the issues that are prevalent to people impacted by AD; already over 250 people have booked to attend.

Panellists include the Minister of State for Pensions, Steve Webb MP; Seth Love, Professor of Neuropathology, University of Bristol; Myra Conway, Associate Professor in Neurochemistry and Dementia, University of the West of England; Beth Britton, Dementia blogger and campaigner and Zara Ross, Head of Care, St Monica Trust.

Jonathan Dimbleby:

“Those who have had any contact with individuals facing dementia or who are concerned that they may themselves develop it, must be aware of how critically important it is for individuals and for our society to understand more about dementia on all its relevant aspects. I very much look forward to chairing what I hope will be an important and stimulating discussion.”

Associate Professor in Neurochemistry and Dementia at UWE Bristol, Myra Conway:

“We are delighted that BRACE has chosen to hold this event at UWE Bristol. We have worked very closely with BRACE over the past few years on funded research to investigate developing biomarkers for AD diagnosis and monitoring. The student Biomedical Society at UWE Bristol also works hard to raise funds for the Charity. There is significant work happening in Bristol at both Universities and Frenchay Hospital to tackle earlier diagnosis.

“One of the biggest problems we face with AD is initial diagnosis; often by the time it is known that someone has the disease it has progressed to such an extent that any medication is largely ineffective. We are looking at ways of using biomarkers to detect the disease earlier and also to track progression. Early indications are that we are moving forward with our insights into misfoldings of proteins in the brain with potentially two new biomarkers. But we still have a very long way to go.

“Working with BRACE to raise awareness of the issues and to share findings is a good step towards generating a better understanding of what is and what is not known about AD and to highlight the importance of continuing investment into AD research.”

BRACE Chief Executive Mark Poarch said he was delighted that Mr Dimbleby had agreed to host the Question Time-style dementia debate.

He said: “We're so grateful that Jonathan has agreed to chair our first Bristol dementia debate. This is a hugely important event for us because it's only by going out in the community and talking about dementia that we can create a united front in the battle against the disease.

“The more people understand about the nature of the illness the more support we can build for the vital research our scientists carry out every day in their bid to find effective treatments for the future.

“This will be a fascinating debate with all angles of the issue covered, from Government policy down to the reality of caring for a person living with dementia.

You can follow the debate live online on BRACE's facebook page and submit your own questions for the panel via Twitter on #discussdementia or by following @AlzheimersBRACE

Admission is by pre booked ticket only and seats are limited. Bookings online at http://www.alzheimers-brace.org/events/brace-dementia-debate

Back to top